PE29698A1 - Derivados de acido quinolon y naftiridoncarboxilico - Google Patents

Derivados de acido quinolon y naftiridoncarboxilico

Info

Publication number
PE29698A1
PE29698A1 PE1995280648A PE28064895A PE29698A1 PE 29698 A1 PE29698 A1 PE 29698A1 PE 1995280648 A PE1995280648 A PE 1995280648A PE 28064895 A PE28064895 A PE 28064895A PE 29698 A1 PE29698 A1 PE 29698A1
Authority
PE
Peru
Prior art keywords
halogen
ome
opt
substd
formula
Prior art date
Application number
PE1995280648A
Other languages
English (en)
Inventor
Uwe Petersen
Rainer Endermann
Thomas Schenke
Klaus-Dieter Bremm
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of PE29698A1 publication Critical patent/PE29698A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SE REFIEREN A LOS COMPUESTOS DE FORMULA "T-Q" EN DONDE: "Q" ES UN RESTO DE FORMULA (i), (ii) o (iii), EN DONDE R1 ES ALQUILO DE C1-C4, SUSTITUIDO DADO EL CASO UNA O DOS VECES POR HALOGENO O HIDROXI, ALQUENILO DE C2-C4, CICLOALQUILO SUSTITUIDO OPCIONALMENTE POR 1 A 2 ATOMOS DE FLUOR, ENTRE OTROS; R2 ES HIDROXI, ALCOXI DE C1-C3, DADO EL CASO SUSTITUIDO POR HIDROXI, METOXI o AMINO, ENTRE OTROS; R9 ES HIDROGENO o ALQUILO DE C1-C3, OPCIONALMENTE SUSTITUIDO POR METOXI, HIDROXI o HALOGENO; R11 ES HIDROGENO, CH3 o CH2F; X1 ES HALOGENO o NITRO, DE PREFERENCIA F o Cl; X2 ES H, HALOGENO o AMINO, ENTRE OTROS; "A" ES N o C-R7, EN DONDE R7 ES HIDROGENO, HALOGENO o CF3, ENTRE OTROS; "T" ES UN RESTO DE FORMULA (iv), EN DONDE "B" ES (CH2)m-NR3R4 o (CH2)m-OR5, DE PREFERENCIA ES NR3R4 o HIDROXI; m ES CERO O UNO; R3 ES HIDROGENO, METILO o ALCOXICARBONILO, DE PREFERENCIA LOS DOS PRIMEROS; R4, R5 Y R6 SON HIDROGENO o METILO; TAMBIEN SE REFIERE AL PROCEDIMIENTO DE PREPARACION DE LOS COMPUESTOS DE FORMULA "T-Q", QUE COMPRENDE: HACER REACCIONAR EL COMPUESTO DE FORMULA "Y-Q", EN DONDE "Q" YA ESTA DEFINIDO e "Y" ES HALOGENO, CON EL COMPUESTO DE FORMULA (iv), DADO EL CASO, EN PRESENCIA DE COLECTORES DE ACIDOS. ESTOS COMPUESTOS PRESENTAN UN EFECTO ANTIBACTERIANO DE AMPLIO ESPECTRO
PE1995280648A 1994-10-04 1995-10-03 Derivados de acido quinolon y naftiridoncarboxilico PE29698A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4435479A DE4435479A1 (de) 1994-10-04 1994-10-04 Chinolon- und Naphthyridoncarbonsäure-Derivate

Publications (1)

Publication Number Publication Date
PE29698A1 true PE29698A1 (es) 1998-08-27

Family

ID=6529941

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1995280648A PE29698A1 (es) 1994-10-04 1995-10-03 Derivados de acido quinolon y naftiridoncarboxilico

Country Status (40)

Country Link
US (1) US5679689A (es)
EP (1) EP0705828B1 (es)
JP (1) JP3794737B2 (es)
KR (1) KR100371883B1 (es)
CN (1) CN1063747C (es)
AT (1) ATE187171T1 (es)
AU (1) AU697608B2 (es)
BG (1) BG62965B1 (es)
CA (1) CA2159547A1 (es)
CO (1) CO4480031A1 (es)
CU (1) CU22751A3 (es)
CZ (1) CZ291616B6 (es)
DE (2) DE4435479A1 (es)
DK (1) DK0705828T3 (es)
DZ (1) DZ1933A1 (es)
EE (1) EE03443B1 (es)
ES (1) ES2140599T3 (es)
FI (1) FI954680A (es)
GR (1) GR3032659T3 (es)
HR (1) HRP950469B1 (es)
HU (1) HUT73429A (es)
IL (2) IL115492A (es)
MA (1) MA23682A1 (es)
MY (1) MY113196A (es)
NO (1) NO307514B1 (es)
NZ (1) NZ280129A (es)
PE (1) PE29698A1 (es)
PL (1) PL182812B1 (es)
PT (1) PT705828E (es)
RO (1) RO115261B1 (es)
RU (1) RU2145604C1 (es)
SG (1) SG38880A1 (es)
SI (1) SI0705828T1 (es)
SK (1) SK280877B6 (es)
SV (1) SV1995000063A (es)
TN (1) TNSN95099A1 (es)
TW (1) TW364908B (es)
UA (1) UA42797C2 (es)
YU (1) YU63595A (es)
ZA (1) ZA958296B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4435479A1 (de) * 1994-10-04 1996-04-11 Bayer Ag Chinolon- und Naphthyridoncarbonsäure-Derivate
DE19751948A1 (de) 1997-11-24 1999-05-27 Bayer Ag Verfahren zur Herstellung von 8-Methoxy-Chinoloncarbonsäuren
US8163769B2 (en) * 2002-03-12 2012-04-24 Abbott Laboratories Antibacterial compounds
JP2006514964A (ja) * 2003-03-12 2006-05-18 アボット・ラボラトリーズ 抗菌剤としてのナフチリジン誘導体
CA2674369C (en) 2007-01-05 2012-04-03 Daiichi Sankyo Company, Limited Fused substituted aminopyrrolidine derivative
PE20231098A1 (es) * 2019-11-28 2023-07-18 Bayer Ag Aminoquinolonas sustituidas como inhibidores de dgk alfa para la activacion inmune
KR102151969B1 (ko) * 2019-12-11 2020-09-04 주식회사 지투비 투과도 가변창의 제조방법 및 그에 의해 제조된 투과도 가변창

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0262875A (ja) * 1988-05-23 1990-03-02 Wakunaga Pharmaceut Co Ltd 新規イソインドリン誘導体
CA2030217A1 (en) * 1989-11-21 1991-05-22 Jun Imose Pyridone-carboxylic acid derivatives useful as veterinary medicines
JPH03181478A (ja) * 1989-12-08 1991-08-07 Banyu Pharmaceut Co Ltd ピリドンカルボン酸誘導体
JPH04253973A (ja) 1990-04-20 1992-09-09 Banyu Pharmaceut Co Ltd ピリドンカルボン酸誘導体
CA2076982A1 (en) * 1990-12-27 1992-06-28 Akira Okura Pyridonecarboxylic acid derivatives
DE4120646A1 (de) 1991-06-22 1992-12-24 Bayer Ag 7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate
DE4121214A1 (de) * 1991-06-27 1993-01-14 Bayer Ag 7-azaisoindolinyl-chinolon- und -naphthyridoncarbonsaeure-derivate
DE4230804A1 (de) * 1992-09-15 1994-03-17 Bayer Ag 7-Isoindolinyl-chinolon- und -naphthyridon-Derivate
DE4329600A1 (de) * 1993-09-02 1995-03-09 Bayer Ag Pyrido [1,2,3-d,e] [1,3,4] benzoxadiazinderivate
DE69526595T2 (de) * 1994-02-04 2002-08-22 Dainippon Pharmaceutical Co., Ltd. Pyridoncarbonsäurederivate substituiert von bicyclischer aminogruppe, deren ester und salze, und bicyclisches amin als zwischenprodukt davon
DE4435479A1 (de) * 1994-10-04 1996-04-11 Bayer Ag Chinolon- und Naphthyridoncarbonsäure-Derivate

Also Published As

Publication number Publication date
ES2140599T3 (es) 2000-03-01
SG38880A1 (en) 1997-04-17
KR960014118A (ko) 1996-05-22
NO953931L (no) 1996-04-09
RU2145604C1 (ru) 2000-02-20
DE4435479A1 (de) 1996-04-11
HU9502888D0 (en) 1995-11-28
SK123895A3 (en) 1996-06-05
HRP950469A2 (en) 1997-08-31
YU63595A (sh) 1998-08-14
EE9500069A (et) 1996-04-15
SK280877B6 (sk) 2000-08-14
TW364908B (en) 1999-07-21
FI954680A0 (fi) 1995-10-02
CA2159547A1 (en) 1996-04-05
NO307514B1 (no) 2000-04-17
HRP950469B1 (en) 2000-12-31
ZA958296B (en) 1996-05-07
ATE187171T1 (de) 1999-12-15
CN1063747C (zh) 2001-03-28
IL115492A (en) 1999-12-22
JPH08225567A (ja) 1996-09-03
FI954680A (fi) 1996-04-05
GR3032659T3 (en) 2000-06-30
IL115492A0 (en) 1996-01-19
AU3291995A (en) 1996-04-18
DE59507324D1 (de) 2000-01-05
NO953931D0 (no) 1995-10-03
SI0705828T1 (en) 2000-02-29
CZ256895A3 (en) 1996-04-17
MY113196A (en) 2001-12-31
KR100371883B1 (ko) 2003-03-29
BG100041A (bg) 1996-05-31
NZ280129A (en) 1996-06-25
MA23682A1 (fr) 1996-07-01
PT705828E (pt) 2000-04-28
CZ291616B6 (cs) 2003-04-16
HUT73429A (en) 1996-07-29
CO4480031A1 (es) 1997-07-09
BG62965B1 (bg) 2000-12-29
RO115261B1 (ro) 1999-12-30
CN1126211A (zh) 1996-07-10
UA42797C2 (uk) 2001-11-15
CU22751A3 (es) 2002-02-28
DZ1933A1 (fr) 2002-02-17
EP0705828A1 (de) 1996-04-10
JP3794737B2 (ja) 2006-07-12
AU697608B2 (en) 1998-10-15
SV1995000063A (es) 1996-07-24
EP0705828B1 (de) 1999-12-01
PL310747A1 (en) 1996-04-15
TNSN95099A1 (fr) 1996-02-06
US5679689A (en) 1997-10-21
IL130921A (en) 2001-10-31
EE03443B1 (et) 2001-06-15
DK0705828T3 (da) 2000-05-15
PL182812B1 (pl) 2002-03-29

Similar Documents

Publication Publication Date Title
AU576302B2 (en) Bridged diazabicycloalkyl quinolone carboxylic acids
KR930016421A (ko) 퀴놀론- 및 나프티리돈-카르복실산 유도체
PE29698A1 (es) Derivados de acido quinolon y naftiridoncarboxilico
FI935557A (fi) Imidazo(1,2-a)(pyrrolo-, tieno- eller furano)(3,2-d)azepinderivat och -kompositioner och foerfarande foer deras anvaendning
AU2025695A (en) 1,9-bridged thiazolo(3,2-a)quinoline derivatives
GR3018746T3 (en) 2-(4-Piperidinyl)-1H-pyrido[4,3-b]indol-1 ones and related compounds, intermediates and a process for their preparation
DK0721948T3 (da) Quinolon- og naphthyridoncarboxylsyrederivater somantibakterielle midler

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed